课题基金 / 基金详情

Cytochrome P450 CYP3A Regulation in Humanized Transgenic Mice

Cytochrome P450 CYP3A Regulation in Humanized Transgenic Mice
人源化转基因小鼠中细胞色素 P450 CYP3A 的调节
批准号:
nhmrc : 211117
负责人:
A/Pr Graham Robertson
金额:
$25.14万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2002
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2002-01-01 至 2004-12-31

项目摘要

项目成果

A/Pr Graham Robertson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The study of the regulation of human genes is inherently difficult. It is difficult or impossible to gain access to many body tissues in either healthy or sick individuals to examine coordinated gene function (or dysfunction). For this reason, it is often the case that we have a much better understanding of gene function in species such as rats and mice, the most common animal environments for biomedical research. However, findings in animals often fail to meaningfully mirror what occurs in man. To progress our understanding of human genes we need to develop models that more faithfully reproduce the human situation in an environment that is amenable to both manipulation and close examination, such as the novel 'humanised' mouse models described in this application. This application deals with the regulation genes that control liver enzymes belonging to the human cytochrome P450 3A (CYP3A) subfamily. These enzymes are present in several tissues including liver, gut, lung and breast. They form the main disposal pathway for foreign chemicals such as drugs, environmental pollutants and some cancer causing chemicals. In addition they are involved in the breakdown of several important internally produced substances, such as steroid hormones. Altered formation of CYP3A enzymes can have a dramatic impact on the action of many important drugs and may predispose to some forms of cancer. In this project, we will insert the genes for all four human CYP3A enzymes into mice. We expect that these 'humanised' mouse models will effectively enable the human situation to be studied in a convenient animal model and allow detailed studies to be performed. A knowledge of the mechanisms involved in CYP3A enzyme formation is of particular importance to the fields of drug and steroid metabolism (both in health and in disease states), liver diseases and foetal pharmacology. In addition, these models will provide a new and useful tool for drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nutrition and rehabilitation in advanced cancer patients
  • 批准号:
    nhmrc : 446208
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $15.07万
  • 财政年份:
    2007
  • 负责人:
    A/Pr Graham Robertson
  • 依托单位:
Expression and regulation of human genes central to drug disposition in the brain
  • 批准号:
    nhmrc : 352320
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $22.63万
  • 财政年份:
    2005
  • 负责人:
    A/Pr Graham Robertson
  • 依托单位:
Repression of hepatic drug metabolism by solid tumours
  • 批准号:
    nhmrc : 352419
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $33.61万
  • 财政年份:
    2005
  • 负责人:
    A/Pr Graham Robertson
  • 依托单位:
Alternate signalling pathways regulating the human arachidonate epoxygenase CYP2J2 in response to stress stimuli
  • 批准号:
    nhmrc : 301909
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $24.6万
  • 财政年份:
    2004
  • 负责人:
    A/Pr Graham Robertson
  • 依托单位:
国内基金
海外基金
底物杂泛性的P450氧化酶的理性改造及其在倍半萜C-H键活化中的应用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    饶历
  • 依托单位:
细菌特殊萜合成酶及P450酶的挖掘与功能研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
白腐真菌Pleurotus ostreatus细胞色素P450酶在药物活性化合物降解中的作用与机制研究
  • 批准号:
    2025JJ50102
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    卓睿
  • 依托单位:
基于细胞色素P450/PPAR/ROS信号通路探究丹参酮IIA 抑制骨丢分子机理
  • 批准号:
    JCZRLH202500148
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: